In addition, the association analysis between the gene alterations of NLRP1 and the clinical survival prognosis of pan‐cancer cases in the TCGA illustrates that the cases with the NLRP1 mutation has a good prognosis in OS (N = 10,803, p = 1.929e‐3) and DSS (N = 10,258, p = 1.355e‐3) (Figure 12C,D). The gene discussed is NLRP1; the disease is cancer.